>AT4G02930.1 |  elongation factor Tu putative / EF-Tu putative 
MASVVLRNPSSKRLVPFSSQIYSRCGASVTSSYSISHSIGGDDLSSSTFGTSSFWRSMAT 
FTRNKPHVNVGTIGHVDHGKTTLTAAITKVLAEEGKAKAIAFDEIDKAPEEKKRGITIAT 
AHVEYETAKRHYAHVDCPGHADYVKNMITGAAQMDGGILVVSGPDGPMPQTKEHILLARQ 
VGVPSLVCFLNKVDVVDDPELLELVEMELRELLSFYKFPGDDIPIIRGSALSALQGTNDE 
IGRQAILKLMDAVDEYIPDPVRVLDKPFLMPIEDVFSIQGRGTVATGRIEQGVIKVGEEV 
EILGLREGGVPLKSTVTGVEMFKKILDNGQAGDNVGLLLRGLKREDIQRGMVIAKPGSCK 
TYKKFEAEIYVLTKDEGGRHTAFFSNYRPQFYLRTADITGKVELPENVKMVMPGDNVTAV 
FELIMPVPLETGQRFALREGGRTVGAGVVSKVMT*
>AT4G11160.1 |  translation initiation factor IF-2 mitochondrial putative 
MPSFLSSLFGLGIQASFRIGLVLPRVVASTERQISSTVLKRASESVSFSFAPYINGFGFS 
SLSNWSRSYESFPTETSIRYFHASRETLAKRKEDADRLLSHRERKKQTVKTKGKFSKREK 
KTDKPPVEAPYVPPRLKRLAKGLPGKTVDIFEGMTLLELSKRTGESVAVLQSILINVGET 
FSSEFDTISVDVAELLAMEIGINVRRQHSTEGSEILPRPPVVTVMGHVDHGKTSLLDALR 
NTSVAAREAGGITQHVGAFVVGMPDSGTSITFLDTPGHAAFSEMRARGAAVTDIVVLVVA 
ADDGVMPQTLEAIAHARSANVPVVVAINKCDKPGANPEKVKYQLTSEGIELEDIGGNVQA 
VEVSAAKSTGLDKLEEALLLQAVDMDLKARVDGPAQAYVVEARLDKGRGPLATIIVKAGT 
LVRGQHVVIGCQWGRLRAIRDMIGKTTDRATPAMPVEIEGLKGLPMAGDDVIVVESEERA 
RMLSEGRKRKYEKDRLLKAEEARLEEAAARLETESEEGFVRVELPIVVKSDVQGTAQAVA 
DALRTLNSPQVSVNIVHSGVGAISHSDLDLAQACGACIVGFNVKGGSTGNLSAAQGSVKV 
FHHRVIYHLLEDIGNLIVEKAPGVSEMEVSGEAEVLSIFKILGKRRTEEDGVNIAGCKVM 
DGRVCRSGLMRLLRSGEVVFEGSCASLKREKQDVEQVGKGNECGLVFGDWNDFRVGDVIQ 
CMEPVIRKPKFISSESGAVRIEC*
>AT4G01370.1 |  ATMPK4 (ARABIDOPSIS THALIANA MAP KINASE 4) MAP kinase/ kinase 
MSAESCFGSSGDQSSSKGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAA 
TNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDV 
YIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 
CDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTR 
EPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSA 
GAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIK 
ELIYRETVKFNPQDSV*
>AT1G80410.1 |  EMB2753 (EMBRYO DEFECTIVE 2753) binding 
MGASLPPKEANLFKLIVKSYETKQYKKGLKAADAILKKFPDHGETLSMKGLTLNCMDRKT 
EAYELVRLGVKNDIKSHVCWHVLGLLYRSDREYREAIKCYRNALRIDPDNLEILRDLSLL 
QAQMRDLSGFVETRQQLLTLKPNHRMNWIGFAVSQHLNANASKAVEILEAYEGTLEDDYP 
PENELIEHTEMILYKVSLLEESGSFDKALEELHKKEPKIVDKLSYKEQEVSLLSKVGRLE 
EANKLYRVLLSMNPDNYRYHEGLQKCLGLYSESGQYSSDQIEKLNALYQSLSEQYTRSSA 
VKRIPLDFLQDENFKEAVAKYIKPLLTKGVPSLFSDLSSLYDHPRKPDILEQLVVEMKHS 
IGTTGSFPGSDVKEPPSTLLWTLFFLAQHYDRRGQYDVALCKIDEAIAHTPTVIDLYSVK 
SRIMKHAGDLTAAAALADEARGMDLADRYINSECVKRMLQADQVPLAEKTAVLFTKEGDQ 
LNNLHDMQCMWYDLASGDSYFRQGDLGRALKKFLAVEKHYADISEDQFDFHSYCLRKMTL 
RSYVDMLKFQDRLHSFPYFHKAAIRAIRCYLKLHDSPKSTAGEDEMSKLAPAQKKKIKKQ 
KKAEARAKKEAESKSEESTASGASKSGKRNVKPVDPDPHGQKLIQVEEPMAEASKYLRLL 
QKHSPNSLETHLLSFEVNMRKQKFLLAFQAVKQLLKLGAENPDSHRSLVKFFLMTESISA 
PTTEAEKLRWRVLEAERPSISQLQNKSLMEANKEFLGRHEDSLVHRAAYAEMLYILDPSK 
KTEAIKIIEDSTNKVVQTNEALGQAREWKLKDCIAVHTLLDTVLLDSQAASRWKSRCAEY 
FPCSTHFEGKHCSLMPDSVYNSSRKSNENGDTPNHPMGQTELSDGQLEAFKSLSVAT*
>AT5G13780.1 |  GCN5-related N-acetyltransferase putative 
MVCIRRATVDDLLAMQACNLMCLPENYQMKYYLYHILSWPQLLYVAEDYNGRIVGYVLAK 
MEEESNECHGHITSLAVLRTHRKLGLATKLMTAAQAAMEQVYEAEYVSLHVRRSNRAAFN 
LYTETLGYKINDVEAKYYADGEDAYDMRKNLKGKQNHHHAHGHHHHHGGGCCSGDAKVVE 
TAQAVDGKAVSK*
>AT2G16880.1 |  pentatricopeptide (PPR) repeat-containing protein 
MATLKPPESQLLKTLTSILTSEKTHFLETLNPYIPQITQPLLTSLLSSPSLAKKPETLVS 
FFQWAQTSIPEAFPSDSPLPLISVVRSLLSHHKFADAKSLLVSYIRTSDASLSLCNSLLH 
PNLHLSPPPSKALFDIALSAYLHEGKPHVALQIFQKMIRLKLKPNLLTCNTLLIGLVRYP 
SSFSISSAREVFDDMVKIGVSLNVQTFNVLVNGYCLEGKLEDALGMLERMVSEFKVNPDN 
VTYNTILKAMSKKGRLSDLKELLLDMKKNGLVPNRVTYNNLVYGYCKLGSLKEAFQIVEL 
MKQTNVLPDLCTYNILINGLCNAGSMREGLELMDAMKSLKLQPDVVTYNTLIDGCFELGL 
SLEARKLMEQMENDGVKANQVTHNISLKWLCKEEKREAVTRKVKELVDMHGFSPDIVTYH 
TLIKAYLKVGDLSGALEMMREMGQKGIKMNTITLNTILDALCKERKLDEAHNLLNSAHKR 
GFIVDEVTYGTLIMGFFREEKVEKALEMWDEMKKVKITPTVSTFNSLIGGLCHHGKTELA 
MEKFDELAESGLLPDDSTFNSIILGYCKEGRVEKAFEFYNESIKHSFKPDNYTCNILLNG 
LCKEGMTEKALNFFNTLIEEREVDTVTYNTMISAFCKDKKLKEAYDLLSEMEEKGLEPDR 
FTYNSFISLLMEDGKLSETDELLKKFSGKFGSMKRDLQVETEKNPATSESKEELNTEAIA 
YSDVIDELCSRGRLKEHSRSYTS*
>AT1G68930.1 |  pentatricopeptide (PPR) repeat-containing protein 
MASNYYSVQIKQCIGLGARNQSRYVKMIHGNIIRALPYPETFLYNNIVHAYALMKSSTYA 
RRVFDRIPQPNLFSWNNLLLAYSKAGLISEMESTFEKLPDRDGVTWNVLIEGYSLSGLVG 
AAVKAYNTMMRDFSANLTRVTLMTMLKLSSSNGHVSLGKQIHGQVIKLGFESYLLVGSPL 
LYMYANVGCISDAKKVFYGLDDRNTVMYNSLMGGLLACGMIEDALQLFRGMEKDSVSWAA 
MIKGLAQNGLAKEAIECFREMKVQGLKMDQYPFGSVLPACGGLGAINEGKQIHACIIRTN 
FQDHIYVGSALIDMYCKCKCLHYAKTVFDRMKQKNVVSWTAMVVGYGQTGRAEEAVKIFL 
DMQRSGIDPDHYTLGQAISACANVSSLEEGSQFHGKAITSGLIHYVTVSNSLVTLYGKCG 
DIDDSTRLFNEMNVRDAVSWTAMVSAYAQFGRAVETIQLFDKMVQHGLKPDGVTLTGVIS 
ACSRAGLVEKGQRYFKLMTSEYGIVPSIGHYSCMIDLFSRSGRLEEAMRFINGMPFPPDA 
IGWTTLLSACRNKGNLEIGKWAAESLIELDPHHPAGYTLLSSIYASKGKWDSVAQLRRGM 
REKNVKKEPGQSWIKWKGKLHSFSADDESSPYLDQIYAKLEELNNKIIDNGYKPDTSFVH 
HDVEEAVKVKMLNYHSERLAIAFGLIFVPSGQPIRVGKNLRVCVDCHNATKHISSVTGRE 
ILVRDAVRFHRFKDGTCSCGDFW*